Skip to main content
OpenTrials

Clinical trial condition

Bile Duct Diseases

Explore clinical trials studying Bile Duct Diseases. Study availability and eligibility vary by location and protocol.

667 public trials 130 recruiting studies
Refine in advanced search Browse all conditions

Bile Duct Diseases trial results

Completed

An Open-Label Study Following Oral Dosing of Seladelpar to Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)

NCT04950764

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +11 more
Locations
  • Arizona Liver Health Chandler, Arizona, United States
  • University of California Davis Sacramento, California, United States
  • University of Colorado Anschutz Aurora, Colorado, United States
  • Mercy Medical Center Baltimore, Maryland, United States
View all 20 locations
View Trial Details
Completed

Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC

NCT03659916

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +3 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital Colorado Denver, Colorado, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
  • Riley Hospital for Children - Riley Children's Specialists Indianapolis, Indiana, United States
View all 41 locations
View Trial Details
Completed

A Study Describing Scratch and Sleep Patterns in Patients With Primary Biliary Cholangitis (Luminaria)

NCT07049887

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Arizona Liver Center Chandler, Arizona, United States
  • University of Miami School of Medicine, Center for Liver Diseases Miami, Florida, United States
  • UT Southwestern Medical Center, Department of Internal Medicine, Digestive and Liver Diseases Dallas, Texas, United States
View Trial Details
Completed

Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)-China Extension Study

NCT04924062

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +14 more
Locations
  • Anhui Provincial Hospital ( Site 0140) Hefei, Anhui, China
  • Beijing Cancer Hospital ( Site 0138) Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital ( Site 0150) Beijing, Beijing Municipality, China
  • First Affiliated Hospital of The Third Military Medical University ( Site 0130) Chongqing, Chongqing Municipality, China
View all 22 locations
View Trial Details

Related conditions